[go: up one dir, main page]

PL376607A1 - Zastosowanie antagonistów oksytocyny i/lub wazopresyny - Google Patents

Zastosowanie antagonistów oksytocyny i/lub wazopresyny

Info

Publication number
PL376607A1
PL376607A1 PL376607A PL37660705A PL376607A1 PL 376607 A1 PL376607 A1 PL 376607A1 PL 376607 A PL376607 A PL 376607A PL 37660705 A PL37660705 A PL 37660705A PL 376607 A1 PL376607 A1 PL 376607A1
Authority
PL
Poland
Prior art keywords
oxytocin
vasopressin
antagonists
application
antagonists oxytocin
Prior art date
Application number
PL376607A
Other languages
English (en)
Inventor
Waldemar Kuczyński
Piotr Pierzyński
Original Assignee
Waldemar Kuczyński
Piotr Pierzyński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waldemar Kuczyński, Piotr Pierzyński filed Critical Waldemar Kuczyński
Priority to PL376607A priority Critical patent/PL376607A1/pl
Priority to RU2007140702/15A priority patent/RU2385735C2/ru
Priority to JP2008511075A priority patent/JP4762308B2/ja
Priority to DE602006021736T priority patent/DE602006021736D1/de
Priority to AT06747719T priority patent/ATE507830T1/de
Priority to KR1020077025706A priority patent/KR100985449B1/ko
Priority to MX2007014022A priority patent/MX2007014022A/es
Priority to SI200631039T priority patent/SI1879572T1/sl
Priority to PL06747719T priority patent/PL1879572T3/pl
Priority to PCT/PL2006/000029 priority patent/WO2006121362A2/en
Priority to NZ562409A priority patent/NZ562409A/en
Priority to AU2006244693A priority patent/AU2006244693B2/en
Priority to CN2006800568367A priority patent/CN101646436B/zh
Priority to DK06747719.0T priority patent/DK1879572T3/da
Priority to ES06747719T priority patent/ES2366130T3/es
Priority to US11/914,049 priority patent/US20080318847A1/en
Priority to PT06747719T priority patent/PT1879572E/pt
Priority to EP06747719A priority patent/EP1879572B1/en
Priority to CA2605923A priority patent/CA2605923C/en
Publication of PL376607A1 publication Critical patent/PL376607A1/pl
Priority to IL186595A priority patent/IL186595A/en
Priority to NO20076328A priority patent/NO340956B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PL376607A 2005-05-10 2005-08-12 Zastosowanie antagonistów oksytocyny i/lub wazopresyny PL376607A1 (pl)

Priority Applications (21)

Application Number Priority Date Filing Date Title
PL376607A PL376607A1 (pl) 2005-08-12 2005-08-12 Zastosowanie antagonistów oksytocyny i/lub wazopresyny
PCT/PL2006/000029 WO2006121362A2 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
CN2006800568367A CN101646436B (zh) 2005-05-10 2006-05-10 催产素和/或血管升压素的拮抗剂在辅助生殖中的应用
DE602006021736T DE602006021736D1 (de) 2005-05-10 2006-05-10 Verwendung von antagonisten von oxytocin und/oder vasopressin bei der assistierten fortpflanzung
AT06747719T ATE507830T1 (de) 2005-05-10 2006-05-10 Verwendung von antagonisten von oxytocin und/oder vasopressin bei der assistierten fortpflanzung
KR1020077025706A KR100985449B1 (ko) 2005-05-10 2006-05-10 옥시톡신 및/또는 바소프레신 길항제의 용도
MX2007014022A MX2007014022A (es) 2005-05-10 2006-05-10 Uso de antagonistas de oxitocina y/o vasopresina en la reproduccion asistida.
SI200631039T SI1879572T1 (sl) 2005-05-10 2006-05-10 Uporaba antagonistov oksitocina in/ali vazopresina pri asistirani reprodukciji
PL06747719T PL1879572T3 (pl) 2005-05-10 2006-05-10 Zastosowanie antagonistów oksytocyny i/lub wazopresyny we wspomaganym rozrodzie
RU2007140702/15A RU2385735C2 (ru) 2005-05-10 2006-05-10 Применение антагонистов окситоцина при вспомогательной репродукции
NZ562409A NZ562409A (en) 2005-05-10 2006-05-10 Use of barusiban in assisted reproduction
AU2006244693A AU2006244693B2 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
JP2008511075A JP4762308B2 (ja) 2005-05-10 2006-05-10 生殖補助におけるオキシトシンのおよび/またはバソプレシンの拮抗薬の使用
DK06747719.0T DK1879572T3 (da) 2005-05-10 2006-05-10 Anvendelse af antagonister af oxytocin og/eller vasopressin i kunstig befrugtning
ES06747719T ES2366130T3 (es) 2005-05-10 2006-05-10 Uso de antagonistas de oxitocina y/o vasopresina en reproducción asistida.
US11/914,049 US20080318847A1 (en) 2005-05-10 2006-05-10 Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
PT06747719T PT1879572E (pt) 2005-05-10 2006-05-10 Uso de antagonistas de oxitocina e/ou vasopressina na reprodução assistida
EP06747719A EP1879572B1 (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction
CA2605923A CA2605923C (en) 2005-05-10 2006-05-10 Use of antagonists of oxytocin and/or vasopressin
IL186595A IL186595A (en) 2005-05-10 2007-10-11 Use of Brosiban for the preparation of drugs to improve uterine absorption during supported fertility
NO20076328A NO340956B1 (no) 2005-05-10 2007-12-10 Anvendelse av antagonister for oksytocin og/eller vasopressin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL376607A PL376607A1 (pl) 2005-08-12 2005-08-12 Zastosowanie antagonistów oksytocyny i/lub wazopresyny

Publications (1)

Publication Number Publication Date
PL376607A1 true PL376607A1 (pl) 2007-02-19

Family

ID=43013708

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376607A PL376607A1 (pl) 2005-05-10 2005-08-12 Zastosowanie antagonistów oksytocyny i/lub wazopresyny

Country Status (1)

Country Link
PL (1) PL376607A1 (pl)

Similar Documents

Publication Publication Date Title
IL185343A0 (en) 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
EP1952334A4 (en) RECOGNITION OF ORDER DUPLICATES WITHIN A COMPANY AND RESPONSE TO THEM
PL2027096T3 (pl) Podstawione aryloimidazolony oraz triazolony jako inhibitory receptorów wazopresyny
EP1812030A4 (en) ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF
EP1786451A4 (en) ANTIANGIOGENIC PEPTIDES AND METHOD FOR THEIR USE
PL2099796T3 (pl) Związki azaindolilowe i sposoby ich zastosowania
IL190217A0 (en) Combination of rosiglitazone and donepezil for improvement of cognitive function
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
IL182494A0 (en) Non-peptide bradykinin antagonists and pharmaceutical composition therefrom
IL185308A0 (en) Replikin peptides and uses thereof
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
IL185223A0 (en) Compounds and uses thereof
IS2463B (is) Útskipt díketópíperasín og notkun þeirra sem oxytósínmótlyfja
DK2392335T3 (en) Use of 24-norUDCA
PL379702A1 (pl) Pochodne benzamidu jako agoniści oksytocyny i antagoniści wazopresyny
IL186606A0 (en) Compositions and uses of amooranin compounds
ZA200707090B (en) 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
ZA200804681B (en) Inhibitors of C-Met and uses thereof
PL376607A1 (pl) Zastosowanie antagonistów oksytocyny i/lub wazopresyny
GB2442418B (en) Construction and use of shortened EG-LDPC codes
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
ZA200802439B (en) Combination of rosiglitazone and donepezil for improvement of cognitive function
ZA200805245B (en) Combination of AXD2171 and pemetrexed
EP1805512A4 (en) PROOF OF BROMAMINES AND CHLORAMINES
ZA200805244B (en) Combination of ZD6474 and pemetrexed

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)